Home › Non-Small Cell Lung Cancer › Texas › Sugar Land
Non-Small Cell Lung Cancer clinical trials in Sugar Land, TX
8 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Sugar Land (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Houston Methodist Sugar Land Hospital, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Kelsey-Seybold Clinic - Fort Bend Campus, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RecruitingPhase 1/2
- Voyage Clinical, Sugar Land
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RecruitingPhase 3
- USO - Texas Oncology Gulf Coast, Sugar Land
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- MD Anderson, Sugar Land
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Sugar Land
- Obesity11 studies
- Overweight10 studies
- Disorders of Excessive Somnolence7 studies
- Breast Cancer7 studies
- Atopic Dermatitis (Eczema)6 studies
- Steatotic Liver Disease6 studies
- Lung Cancer6 studies
- Type 2 Diabetes5 studies
- Sleep Disorders5 studies
- Pneumococcal Infections4 studies
- Narcolepsy4 studies
- Metastatic Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.